ResearcherKyung Hee UniversityNo recent work listed
Jong-Ho Kim
Matched on ORCID iD 0000-0002-6091-6251; OpenAlex author ID A5100427734. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 3
- Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy. Last author DOI 10.1186/s40824-023-00394-7↗
- Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer. Co-author DOI 10.3390/molecules27082529↗
- Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy. Last author DOI 10.1016/j.jconrel.2021.01.031↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- In Kyung Cho · 3 shared papers, 2021–2023 · strength 0.53
- Paper Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer. DOI 10.3390/molecules27082529↗
- Paper Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy. DOI 10.1186/s40824-023-00394-7↗
- Paper Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic c… DOI 10.1016/j.jconrel.2021.01.031↗
- Man Kyu Shim · 3 shared papers, 2021–2023 · strength 0.53
- Paper Light-Activated Monomethyl Auristatin E Prodrug Nanoparticles for Combinational Photo-Chemotherapy of Pancreatic Cancer. DOI 10.3390/molecules27082529↗
- Paper Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy. DOI 10.1186/s40824-023-00394-7↗
- Paper Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic c… DOI 10.1016/j.jconrel.2021.01.031↗
- Kwangmeyung Kim · 1 shared paper, 2022 · strength 0.20
- Wooram Um · 1 shared paper, 2022 · strength 0.20
- Chaeeun Bang · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.